Polyanions and the proteome

Molecular and Cellular Proteomics

Volumn 3, Issue 8, 2004, Pages 746-769

  Jones, LaToya S ^a   Yazzie, Brian ^a   Middaugh, C Russell ^a  

^a UNIVERSITY OF KANSAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; AMYLOID BETA PROTEIN; CHAPERONE; CHONDROITIN SULFATE; DEXTRAN SULFATE; DNA; E1A PROTEIN; ENZYME PRECURSOR; FIBROBLAST GROWTH FACTOR 1; FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTOR RECEPTOR 2; GLYCOSAMINOGLYCAN; GLYCOSAMINOGLYCAN POLYSULFATE; HEPARIN; INOSITOL HEXASULFATE; INOSITOL POLYPHOSPHATE; KERATAN SULFATE; KERATINOCYTE GROWTH FACTOR; PENTOSAN POLYSULFATE; POLYANION; POLYGLUTAMINE; POLYNUCLEOTIDE; PRION PROTEIN; PROTEOME; SUCRALFATE; SUPEROXIDE DISMUTASE; SURAMIN; TAU PROTEIN; UNINDEXED DRUG; VIRUS PROTEIN;

AMYLOIDOSIS; ANTIVIRAL ACTIVITY; BACTERIAL INFECTION; CANCER; CELLULAR PARAMETERS; CHROMATOGRAPHY; CLINICAL TRIAL; DEGENERATIVE DISEASE; DIGESTIVE SYSTEM ULCER; DRUG EFFICACY; DRUG PROTEIN BINDING; HUMAN; LIPID BILAYER; MICROFILAMENT; MICROTUBULE; MOLECULAR INTERACTION; NONHUMAN; ONCHOCERCIASIS; OSTEOARTHRITIS; PAIN; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DATABASE; PROTEIN DOMAIN; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; PROTEIN TRANSPORT; REGULATORY MECHANISM; REVIEW; SIDE EFFECT; TRYPANOSOMIASIS; TWO DIMENSIONAL ELECTROPHORESIS; VIRUS INFECTION;

ANIMALS; BIOLOGICAL TRANSPORT; HUMANS; POLYMERS; PROTEIN ARRAY ANALYSIS; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN INTERACTION MAPPING; PROTEINS; PROTEOME;

BACTERIA (MICROORGANISMS);

EID: 4444271312     PISSN: 15359476     EISSN: None     Source Type: Journal    
DOI: 10.1074/mcp.R400008-MCP200     Document Type: Review

References (172)

1. Ptashne, M., and Gann, A. (2002) Genes and Signals, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
2. Medalia, O., Weber, I., Frangakis, A. S., Nicastro, D., Gerisch, G., and Baumeister, W. (2002) Macromolecular architecture in eukaryotic cells visualized by cryoelectron tomography. Science 298, 1209-1213
3. Conrad, H. E. (1998) Heparin-binding proteins, Academic Press, San Diego, CA
4. Ribatti, D., Vacca, A., and Presta, M. (2000) The discovery of angiogenic factors: A historical review. Gen. Pharmacol. 35, 227-231.
5. Shing, Y., Folkman, J., Sullivan, R., Butterfield, C., Murray, J., and Klagsbrun, M. (1984) Heparin affinity: Purification of a tumor-derived capillary endothelial cell growth factor. Science 223, 1296-1299
6. Pye, D. A., Vives, R. R., Hyde, P., and Gallagher, J. T. (2000) Regulation of FGF-1 mitogenic activity by heparan sulfate oligosaccharides is dependent on specific structural features: Differential requirements for the modulation of FGF-1 and FGF-2. Glycobiology 10, 1183-1192
7. Catlow, K., Deakin, J. A., Delehedde, M., Fernig, D. G., Gallagher, J. T., Pavao, M. S., and Lyon, M. (2003) Hepatocyte growth factor/scatter factor and its interaction with heparan sulphate and dermatan sulphate. Biochem. Soc. Trans. 31, 352-353
8. Schlessinger, J., Plotnikov, A. N., Ibrahimi, O. A., Eliseenkova, A. V., Yeh, B. K., Yayon, A., Linhardt, R. J., and Mohammadi, M. (2000) Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization. Mol. Cell 6, 743-750
9. Ye, S., Luo, Y., Lu, W., Jones, R. B., Linhardt, R. J., Capila, I., Toida, T., Kan, M., Pelletier, H., and McKeehan, W. L. (2001) Structural basis for interaction of FGF-1, FGF-2, and FGF-7 with different heparan sulfate motifs. Biochemistry 40, 14429-14439
10. Yeh, B. K., Eliseenkova, A. V., Plotnikov, A. N., Green, D., Pinnell, J., Polat, T., Gritli-Linde, A., Linhardt, R. J., and Mohammadi, M. (2002) Structural basis for activation of fibroblast growth factor signaling by sucrose octasulfate. Mol. Cell. Biol. 22, 7184-7192
11. Zhu, X., Hsu, B. T., and Rees, D.C. (1993) Structural studies of the binding of the anti-ulcer drug sucrose octasulfate to acidic fibroblast growth factor. Structure 1, 27-34
12. Zhu, X., Komiya, H., Chirino, A., Faham, S., Fox, G. M., Arakawa, T., Hsu, B. T., and Rees, D. C. (1991) Three-dimensional structures of acidic and basic fibroblast growth factors. Science 251, 90-93
13. Chavan, A. J., Haley, B. E., Volkin, D. B., Marfia, K. E., Verticelli, A. M., Bruner, M. W., Draper, J. P., Burke, C. J., and Middaugh, C. R. (1994) Interaction of nucleotides with acidic fibroblast growth factor (FGF-1). Biochemistry 33, 7193-7202
14. Pellegrini, L., Burke, D. F., von Delft, F., Mulloy, B., and Blundell, T. L. (2000) Crystal structure of fibroblast growth factor receptor ectodomain bound to ligand and heparin. Nature 407, 1029-1034
15. Plotnikov, A. N., Schlessinger, J., Hubbard, S. R., and Mohammadi, M. (1999) Structural basis for FGF receptor dimerization and activation. Cell 98, 641-650
16. Burke, C. J., Volkin, D. B., Mach, H., and Middaugh, C. R. (1993) Effect of polyanions on the unfolding of acidic fibroblast growth factor. Biochemistry 32, 6419-6426
17. Mach, H., Ryan, J. A., Burke, C. J., Volkin, D. B., and Middaugh, C. R. (1993) Partially structured self-associating states of acidic fibroblast growth factor. Biochemistry 32, 7703-7711
18. Middaugh, C. R., Mach, H., Burke, C. J., Volkin, D. B., Dabora, J. M., Tsai, P. K., Bruner, M. W., Ryan, J. A., and Marfia, K. E. (1992) Nature of the interaction of growth factors with suramin. Biochemistry 31, 9016-9024
19. Tsai, P. K., Volkin, D. B., Dabora, J. M., Thompson, K. C., Bruner, M. W., Gress, J. O., Matuszewska, B., Keogan, M., Bondi, J. V., and Middaugh, C. R. (1993) Formulation design of acidic fibroblast growth factor. Pharm. Res. 10, 649-659
20. Volkin, D. B., Tsai, P. K., Dabora, J. M., Gress, J. O., Burke, C. J., Linhardt, R. J., and Middaugh, C. R. (1993) Physical stabilization of acidic fibroblast growth factor by polyanions. Arch. Biochem. Biophys. 300, 30-41
21. Volkin, D. B., Verticelli, A. M., Marfia, K. E., Burke, C. J., Mach, H., and Middaugh, C. R. (1993) Sucralfate and soluble sucrose octasulfate bind and stabilize acidic fibroblast growth factor. Biochim. Biophys. Acta 1203, 18-26
22. Volkin, D. B., Verticelli, A. M., Bruner, M. W., Marfia, K. E., Tsai, P. K., Sardana, M. K., and Middaugh, C. R. (1995) Deamidation of polyanion-stabilized acidic fibroblast growth factor. J. Pharm. Sci. 84, 7-11
23. Dabora, J. M., Sanyal, G., and Middaugh, C. R. (1991) Effect of polyanions on the refolding of human acidic fibroblast growth factor. J. Biol. Chem. 266, 23637-23640
24. Edwards, K. L., Kueltzo, L. A., Fisher, M. T., and Middaugh, C. R.(2001) Complex effects of molecular chaperones on the aggregation and refolding of fibroblast growth factor-1. Arch. Biochem. Biophys. 393, 14-21
25. Mach, H., and Middaugh, C. R. (1995) Interaction of partially structured states of acidic fibroblast growth factor with phospholipid membranes. Biochemistry 34, 9913-9920
26. Kueltzo, L. A., and Middaugh, C. R. (2003) Nonclassical transport proteins and peptides: An alternative to classical macromolecule delivery systems. J. Pharm. Sci. 92, 1754-1772
27. Kueltzo, L. A., and Middaugh, C. R. (2000) Potential use of non-classical pathways for the transport of macromolecular drugs. Expert Opin. Investig. Drugs 9, 2039-2050
28. Copeland, R. A., Ji, H., Halfpenny, A. J., Williams, R. W., Thompson, K. C., Herber, W. K., Thomas, K. A., Bruner, M. W., Ryan, J. A., Marquis-Omer, D., et al. (1991) The structure of human acidic fibroblast growth factor and its interaction with heparin. Arch. Biochem. Biophys. 289, 53-61
29. Faham, S., Hileman, R. E., Fromm, J. R., Linhardt, R. J., and Rees, D. C. (1996) Heparin structure and interactions with basic fibroblast growth factor. Science 271, 1116-1120
30. Mach, H., Volkin, D. B., Burke, C. J., Middaugh, C. R., Linhardt, R. J., Fromm, J. R., Loganathan, D., and Mattsson, L. (1993) Nature of the interaction of heparin with acidic fibroblast growth factor. Biochemistry 32, 5480-5489
31. Mach, H., and Middaugh, C. R. (1994) Probing the affinity of polyanions for acidic fibroblast growth factor by unfolding kinetics. Arch. Biochem. Biophys. 309, 36-42
32. Weiner, H. L., and Swain, J. L. (1989) Acidic fibroblast growth factor mRNA is expressed by cardiac myocytes in culture and the protein is localized to the extracellular matrix. Proc. Natl. Acad. Sci. U. S. A. 86, 2683-2687
33. Vlodavsky, I., Folkman, J., Sullivan, R., Fridman, R., Ishai-Michaeli, R., Sasse, J., and Klagsbrun, M. (1987) Endothelial cell-derived basic fibroblast growth factor: Synthesis and deposition into subendothelial extracellular matrix. Proc. Natl. Acad. Sci. U. S. A. 84, 2292-2296
34. Bashkin, P., Doctrow, S., Klagsbrun, M., Svahn, C. M., Folkman, J., and Vlodavsky, I. (1989) Basic fibroblast growth factor binds to subendothelial extracellular matrix and is released by heparitinase and heparin-like molecules. Biochemistry 28, 1737-1743
35. Baird, A., and Ling, N. (1987) Fibroblast growth factors are present in the extracellular matrix produced by endothelial cells in vitro: Implications for a role of heparinase-like enzymes in the neovascular response. Biochem. Biophys. Res. Commun. 142, 428-435
36. Van Dyk, T. K., Gatenby, A. A., and LaRossa, R. A. (1989) Demonstration by genetic suppression of interaction of GroE products with many proteins. Nature 342, 451-453
37. Rentzeperis, D., Jonsson, T., and Sauer, R. T. (1999) Acceleration of the refolding of Arc repressor by nucleic acids and other polyanions. Nat. Struct. Biol. 6, 569-573
38. Manna, T., Sarkar, T., Poddar, A., Roychowdhury, M., Das, K. P., and Bhattacharyya, B. (2001) Chaperone-like activity of tubulin, binding and reactivation of unfolded substrate enzymes. J. Biol. Chem. 276, 39742-39747
39. Csermely, P., and Kahn, C. R. (1991) The 90-kDa heat shock protein (hsp-90) possesses an ATP binding site and autophosphorylating activity. J. Biol. Chem. 266, 4943-4950
40. Nishida, E., Koyasu, S., Sakai, H., and Yahara, I. (1986) Calmodulin-regulated binding of the 90-kDa heat shock protein to actin filaments. J. Biol. Chem. 261, 16033-16036
41. Koyasu, S., Nishida, E., Kadowaki, T., Matsuzaki, F., Iida, K., Harada, F., Kasuga, M., Sakai, H., and Yahara, I. (1986) Two mammalian heat shock proteins, HSP90 and HSP100, are actin-binding proteins. Proc. Natl. Acad. Sci. U. S. A. 83, 8054-8058
42. Liang, P., and MacRae, T. H. (1997) Molecular chaperones and the cytoskeleton. J. Cell Sci. 110, 1431-1440
43. Hino, M., Kurogi, K., Okubo, M. A., Murata-Hori, M., and Hosoya, H. (2000) Small heat shock protein 27 (HSP27) associates with tubulin/microtubules in HeLa cells. Biochem. Biophys. Res. Commun. 271, 164-169
44. Staker, B. L., Korber, P., Bardwell, J. C., and Saper, M. A. (2000) Structure of Hsp15 reveals a novel RNA-binding motif. EMBO J. 19, 749-757
45. Korber, P., Stahl, J. M., Nierhaus, K. H., and Bardwell, J. C. (2000) Hsp15: A ribosome-associated heat shock protein. EMBO J. 19, 741-748
46. Korber, P., Zander, T., Herschlag, D., and Bardwell, J. C. (1999) A new heat shock protein that binds nucleic acids. J. Biol. Chem. 274, 249-256
47. Menoret, A., and Bell, G. (2002) Purification of multiple heat shock proteins from a single tumor sample. J. Immunol. Methods 237, 119-130
48. Weller, N. K. (1988) A 70 kDa microtubule-associated protein in NIL8 cells comigrates with the 70 kDa heat shock protein. Biol. Cell 63, 307-317
49. Green, L. A., and Liem, R. K. (1989) Beta-internexin is a microtubule-associated protein identical to the 70-kDa heat-shock cognate protein and the clathrin uncoating ATPase. J. Biol. Chem. 264, 15210-15215
50. Bloch, M. A., and Johnson, K. A. (1995) Identification of a molecular chaperone in the eukaryotic flagellum and its localization to the site of microtubule assembly. J. Cell Sci. 108, 3541-3545
51. Mounier, N., and Arrigo, A. P. (2002) Actin cytoskeleton and small heat shock proteins: how do they interact? Cell Stress Chaperones 7, 167-176
52. Narberhaus, F. (2002) Alpha-crystallin-type heat shock proteins: Socializing minichaperones in the context of a multichaperone network. Microbiol. Mol. Biol. Rev. 66, 64-93
53. Basha, E., Lee, G. J., Breci, L. A., Hausrath, A. C., Buan, N. R., Giese, K. C., and Vierling, E. (2004) The identity of proteins associated with a small heat shock protein during heat stress in vivo indicates that these chaperones protect a wide range of cellular functions. J. Biol. Chem. 279, 7566-7575
54. Park, S. M., Jung, H. Y., Kim, T. D., Park, J. H., Yang, C. H., and Kim, J. (2002) Distinct roles of the N-terminal-binding domain and the C-terminal-solubilizing domain of alpha-synuclein, a molecular chaperone. J. Biol. Chem. 277, 28512-28520
55. Hingorani, K., Szebeni, A., and Olson, M. O. (2000) Mapping the functional domains of nucleolar protein B23. J. Biol. Chem. 275, 24451-24457
56. Szebeni, A., and Olson, M. O. (1999) Nucleolar protein B23 has molecular chaperone activities. Protein Sci. 8, 905-912
57. Szebeni, A., Hingorani, K., Negi, S., and Olson, M. O. (2003) Role of protein kinase CK2 phosphorylation in the molecular chaperone activity of nucleolar protein b23. J. Biol. Chem. 278, 9107-9115
58. Guha, S., Manna, T. K., Das, K. P., and Bhattacharyya, B. (1998) Chaperone-like activity of tubulin. J. Biol. Chem. 273, 30077-30080
59. Wu, Z., Powell, R., and Lu, W. (2003) Productive folding of human neutrophil alpha-defensins in vitro without the pro-peptide. J. Am. Chem. Soc. 125, 2402-2403
60. Zhu, X. L., Ohta, Y., Jordan, F., and Inouye, M. (1989) Pro-sequence of subtilisin can guide the refolding of denatured subtilisin in an intermolecular process. Nature 339, 483-484
61. Silen, J. L., and Agard, D. A. (1989) The alpha-lytic protease pro-region does not require a physical linkage to activate the protease domain in vivo. Nature 341, 462-464
62. Venekei, I., Graf, L., and Rutter, W. J. (1996) Expression of rat chymotrypsinogen in yeast: A study on the structural and functional significance of the chymotrypsinogen propeptide. FEBS Lett. 379, 139-142
63. Brogden, K. A., Ackermann, M., and Huttner, K. M. (1997) Small, anionic, and charge-neutralizing propeptide fragments of zymogens are antimicrobial. Antimicrob. Agents Chemother. 41, 1615-1617
64. Liu, F., Zaidi, T., Iqbal, K., Grundke-Iqbal, I., and Gong, C. X. (2002) Aberrant glycosylation modulates phosphorylation of tau by protein kinase A and dephosphorylation of tau by protein phosphatase 2A and 5. Neuroscience 115, 829-837
65. Bodwell, J. E., Hu, L. M., Hu, J. M., Orti, E., and Munck, A. (1993) Glucocorticoid receptors: ATP-dependent cycling and hormone-dependent hyperphosphorylation. J. Steroid Biochem. Mol. Biol. 47, 31-38
66. Orti, E., Hu, L. M., and Munck, A. (1993) Kinetics of glucocorticoid receptor phosphorylation in intact cells. Evidence for hormone-induced hyperphosphorylation after activation and recycling of hyperphosphorylated receptors. J. Biol. Chem. 268, 7779-7784
67. Vivanco, I., and Sawyers, C. L. (2002) The phosphatidylinositol 3-kinase AKT pathway in human cancer. Nat. Rev. Cancer 2, 489-501
68. Goedert, M., Jakes, R., Spillantini, M. G., Hasegawa, M., Smith, M. J., and Crowther, R. A. (1996) Assembly of microtubule-associated protein tau into Alzheimer-like filaments induced by sulphated glycosaminoglycans. Nature 383, 550-553
69. Gong, C. X., Liu, F., Wu, G., Rossie, S., Wegiel, J., Li, L., Grundke-Iqbal, I., and Iqbal, K. (2004) Dephosphorylation of microtubule-associated protein tau by protein phosphatase 5. J. Neurochem. 88, 298-310
70. Niethammer, P., Bastiaens, P., and Karsenti, E. (2004) Stathmin-tubulin interaction gradients in motile and mitotic cells. Science 303, 1862-1866
71. Kirfel, J., Magin, T. M., and Reichelt, J. (2003) Keratins: A structural scaffold with emerging functions. Cell Mol. Life Sci. 60, 56-71
72. Leifert, J. A., and Whitton, J. L. (2003) "Translocatory proteins" and "protein transduction domains": A critical analysis of their biological effects and the underlying mechanisms. Mol. Ther. 8, 13-20
73. Kabouridis, P. S. (2003) Biological applications of protein transduction technology. Trends Biotechnol. 21, 498-503
74. Kumagai, A. K., Eisenberg, J. B., and Pardridge, W. M. (1987) Absorptive-mediated endocytosis of cationized albumin and a beta-endorphin-cationized albumin chimeric peptide by isolated brain capillaries. Model system of blood-brain barrier transport. J. Biol. Chem. 262, 15214-15219
75. Smith, K. R., and Borchardt, R. T. (1989) Permeability and mechanism of albumin, cationized albumin, and glycosylated albumin transcellular transport across monolayers of cultured bovine brain capillary endothelial cells. Pharm. Res. 6, 466-473
76. Pardridge, W. M., Kumagai, A. K., and Eisenberg, J. B. (1987) Chimeric peptides as a vehicle for peptide pharmaceutical delivery through the blood-brain barrier. Biochem. Biophys. Res. Commun. 146, 307-313
77. Chuang, V. T., Kragh-Hansen, U., and Otagiri, M. (2002) Pharmaceutical strategies utilizing recombinant human serum albumin. Pharm. Res. 19, 569-577
78. Triguero, D., Buciak, J. B., Yang, J., and Pardridge, W. M. (1989) Blood-brain barrier transport of cationized immunoglobulin G: Enhanced delivery compared to native protein. Proc. Natl. Acad. Sci. U. S. A. 86, 4761-4765
79. Tyagi, M., Rusnati, M., Presta, M., and Giacca, M. (2001) Internalization of HIV-1 tat requires cell surface heparan sulfate proteoglycans. J. Biol. Chem. 276, 3254-3261
80. Hakansson, S., Jacobs, A., and Caffrey, M. (2001) Heparin binding by the HIV-1 tat protein transduction domain. Protein Sci. 10, 2138-2139
81. Hakansson, S., and Caffrey, M. (2003) Structural and dynamic properties of the HIV-1 tat transduction domain in the free and heparin-bound states. Biochemistry 42, 8999-9006
82. Rusnati, M., Urbinati, C., Caputo, A., Possati, L., Lortat-Jacob, H., Giacca, M., Ribatti, D., and Presta, M. (2001) Pentosan polysulfate as an inhibitor of extracellular HIV-1 Tat. J. Biol. Chem. 276, 22420-22425
83. Rusnati, M., Tulipano, G., Spillmann, D., Tanghetti, E., Oreste, P., Zoppetti, G., Giacca, M., and Presta, M. (1999) Multiple interactions of HIV-I Tat protein with size-defined heparin oligosaccharides. J. Biol. Chem. 274, 28198-28205
84. Rusnati, M., Tulipano, G., Urbinati, C., Tanghetti, E., Giuliani, R., Giacca, M., Ciomei, M., Corallini, A., and Presta, M. (1998) The basic domain in HIV-1 Tat protein as a target for polysulfonated heparin-mimicking extracellular Tat antagonists. J. Biol. Chem. 273, 16027-16037
85. Rusnati, M., Coltrini, D., Oreste, P., Zoppetti, G., Albini, A., Noonan, D., d'Adda di Fagagna, F., Giacca, M., and Presta, M. (1997) Interaction of HIV-1 Tat protein with heparin. Role of the backbone structure, sulfation, and size. J. Biol. Chem. 272, 11313-11320
86. Sandgren, S., Cheng, F., and Belting, M. (2002) Nuclear targeting of macromolecular polyanions by an HIV-Tat derived peptide. Role for cell-surface proteoglycans. J. Biol. Chem. 277, 38877-38883
87. Console, S., Marty, C., Garcia-Echeverria, C., Schwendener, R., and Ballmer-Hofer, K. (2003) Antennapedia and HIV transactivator of transcription (TAT) "protein transduction domains" promote endocytosis of high molecular weight cargo upon binding to cell surface glycosaminoglycans. J. Biol. Chem. 278, 35109-35114
88. Joliot, A. H., Triller, A., Volovitch, M., Pernelle, C., and Prochiantz, A. (1991) Alpha-2,8-polysialic acid is the neuronal surface receptor of antennapedia homeobox peptide. New Biol. 3, 1121-1134
89. Schwartz, J. J., and Zhang, S. (2000) Peptide-mediated cellular delivery. Curr. Opin. Mol. Ther. 2, 162-167
90. Kueltzo, L. A., Normand, N., O'Hare, P., and Middaugh, C. R. (2000) Conformational lability of herpesvirus protein VP22. J. Biol. Chem. 275, 33213-33221
91. Wiedlocha, A., Madshus, I. H., Mach, H., Middaugh, C. R., and Olsnes, S. (1992) Tight folding of acidic fibroblast growth factor prevents its translocation to the cytosol with diphtheria toxin as vector. EMBO J. 11, 4835-4842
92. Mitchell, D. J., Kim, D. T., Steinman, L., Fathman, C. G., and Rothbard, J. B. (2000) Polyarginine enters cells more efficiently than other polycationic homopolymers. J. Pept. Res. 56, 318-325
93. Futaki, S. (2002) Arginine-rich peptides: potential for intracellular delivery of macromolecules and the mystery of the translocation mechanisms. Int. J. Pharm. 245, 1-7
94. Rudolph, C., Plank, C., Lausier, J., Schillinger, U., Muller, R. H., and Rosenecker, J. (2003) Oligomers of the arginine-rich motif of the HIV-1 TAT protein are capable of transferring plasmid DNA into cells. J. Biol. Chem. 278, 11411-11418
95. Futaki, S., Goto, S., Suzuki, T., Nakase, I., and Sugiura, Y. (2003) Structural variety of membrane permeable peptides. Curr. Protein Pept. Sci. 4, 87-96
96. Wiethoff, C. M., Smith, J. G., Koe, G. S., and Middaugh, C. R. (2001) The potential role of proteoglycans in cationic lipid-mediated gene delivery. Studies of the interaction of cationic lipid-DNA complexes with model glycosaminoglycans. J. Biol. Chem. 276, 32806-32813
97. Ruponen, M., Yla-Herttuala, S., and Urtti, A. (1999) Interactions of polymeric and liposomal gene delivery systems with extracellular glycosaminoglycans: Physicochemical and transfection studies. Biochim. Biophys. Acta 1415, 331-341
98. Belting, M., and Petersson, P. (1999) Intracellular accumulation of secreted proteoglycans inhibits cationic lipid-mediated gene transfer. Cotransfer of glycosaminoglycans to the nucleus. J. Biol. Chem. 274, 19375-19382
99. Mislick, K. A., and Baldeschwieler, J. D. (1996) Evidence for the role of proteoglycans in cation-mediated gene transfer. Proc. Natl. Acad. Sci. U. S. A. 93, 12349-12354
100. Zelphati, O., Uyechi, L. S., Barron, L. G., and Szoka, F. C., Jr. (1998) Effect of serum components on the physico-chemical properties of cationic lipid/oligonucleotide complexes and on their interactions with cells. Biochim. Biophys. Acta 1390, 119-133
101. Xu, Y., and Szoka, F. C., Jr. (1996) Mechanism of DNA release from cationic liposome/DNA complexes used in cell transfection. Biochemistry 35, 5616-5623
102. Wiethoff, C. M., and Middaugh, C. R. (2003) Barriers to nonviral gene delivery. J. Pharm. Sci. 92, 203-217
103. Cotman, +S. L., Halfter, W., and Cole, G. J. (2000) Agrin binds to beta-amyloid (Aβ), accelerates Aβ fibril formation, and is localized to Aβ deposits in Alzheimer's disease brain. Mol. Cell Neurosci. 15, 183-198
104. Donahue, J. E., Berzin, T. M., Rafii, M. S., Glass, D. J., Yancopoulos, G. D., Fallon, J. R., and Stopa, E. G. (1999) Agrin in Alzheimer's disease: Altered solubility and abnormal distribution within microvasculature and brain parenchyma. Proc. Natl. Acad. Sci. U. S. A. 96, 6468-6472
105. Verbeek, M. M., Otte-Holler, I., van den Born, J., van den Heuvel, L. P., David, G., Wesseling, P., and de Waal, R. M. (1999) Agrin is a major heparan sulfate proteoglycan accumulating in Alzheimer's disease brain. Am. J. Pathol. 155, 2115-2125
106. Castillo, G. M., Lukito, W., Wight, T. N., and Snow, A. D. (1999) The sulfate moieties of glycosaminoglycans are critical for the enhancement of beta-amyloid protein fibril formation. J. Neurochem. 72, 1681-1687
107. McLaurin, J., Franklin, T., Zhang, X., Deng, J., and Fraser, P. E. (1999) Interactions of Alzheimer amyloid-beta peptides with glycosaminoglycans effects on fibril nucleation and growth. Eur. J. Biochem. 266, 1101-1110
108. Watson, D. J., Lander, A. D., and Selkoe, D. J. (1997) Heparin-binding properties of the amyloidogenic peptides Abeta and amylin. Dependence on aggregation state and inhibition by Congo red. J. Biol. Chem. 272, 31617-31624
109. Makrides, V., Massie, M. R., Feinstein, S. C., and Lew, J. (2004) Evidence for two distinct binding sites for tau on microtubules. Proc. Natl. Acad. Sci. U. S. A. 101, 6746-6751
110. Dou, F., Netzer, W. J., Tanemura, K., Li, F., Hartl, F. U., Takashima, A., Gouras, G. K., Greengard, P., and Xu, H. (2003) Chaperones increase association of tau protein with microtubules. Proc. Natl. Acad. Sci. U. S. A. 100, 721-726
111. Hasegawa, M., Crowther, R. A., Jakes, R., and Goedert, M. (1997) Alzheimer-like changes in microtubule-associated protein Tau induced by sulfated glycosaminoglycans. Inhibition of microtubule binding, stimulation of phosphorylation, and filament assembly depend on the degree of sulfation. J. Biol. Chem. 272, 33118-33124
112. Scholefield, Z., Yates, E. A., Wayne, G., Amour, A., McDowell, W., and Turnbull, J. E. (2003) Heparan sulfate regulates amyloid precursor protein processing by BACE1, the Alzheimer's beta-secretase. J. Cell Biol. 163, 97-107
113. Brimacombe, D. B., Bennett, A. D., Wusteman, F. S., Gill, A. C., Dann, J. C., and Bostock, C. J. (1999) Characterization and polyanion-binding properties of purified recombinant prion protein. Biochem. J. 342, 605-613
114. Gonzalez-Iglesias, R., Pajares, M. A., Ocal, C., Espinosa, J. C., Oesch, B., and Gasset, M. (2002) Prion protein interaction with glycosaminoglycan occurs with the formation of oligomeric complexes stabilized by Cu(II) bridges. J. Mol. Biol. 319, 527-540
115. Warner, R. G., Hundt, C., Weiss, S., and Turnbull, J. E. (2002) Identification of the heparan sulfate binding sites in the cellular prion protein. J. Biol. Chem. 277, 18421-18430
116. Ben-Zaken, O., Tzaban, S., Tal, Y., Horonchik, L., Esko, J. D., Vlodavsky, I., and Taraboulos, A. (2003) Cellular heparan sulfate participates in the metabolism of prions. J. Biol. Chem. 278, 40041-40049
117. Caughey, B., and Raymond, G. J. (1993) Sulfated polyanion inhibition of scrapie-associated PrP accumulation in cultured cells. J. Virol. 67, 643-650
118. Gabizon, R., Meiner, Z., Halimi, M., and Ben-Sasson, S. A. (1993) Heparin-like molecules bind differentially to prion-proteins and change their intracellular metabolic fate. J. Cell. Physiol. 157, 319-325
119. Lasmezas, C. I. (2003) Putative functions of PrP(C). Br. Med. Bull. 66, 61-70
120. Caughey, B., Brown, K., Raymond, G. J., Katzenstein, G. E., and Thresher, W. (1994) Binding of the protease-sensitive form of PrP (prion protein) to sulfated glycosaminoglycan and congo red [corrected]. J. Virol. 68, 2135-2141
121. Cohlberg, J. A., Li, J., Uversky, V. N., and Fink, A. L. (2002) Heparin and other glycosaminoglycans stimulate the formation of amyloid fibrils from alpha-synuclein in vitro. Biochemistry 41, 1502-1511
122. Antony, T., Hoyer, W., Cherny, D., Heim, G., Jovin, T. M., and Subramaniam, V. (2003) Cellular polyamines promote the aggregation of alpha-synuclein. J. Biol. Chem. 278, 3235-3240
123. Goers, J., Uversky, V. N., and Fink, A. L. (2003) Polycation-induced oligomerization and accelerated fibrillation of human alpha-synuclein in vitro. Protein Sci. 12, 702-707
124. Weis, W., Brown, J. H., Cusack, S., Paulson, J. C., Skehel, J. J., and Wiley, D. C. (1988) Structure of the influenza virus haemagglutinin complexed with its receptor, sialic acid. Nature 333, 426-431
125. Suzuki, Y., Nagao, Y., Kato, H., Matsumoto, M., Nerome, K., Nakajima, K., and Nobusawa, E. (1986) Human influenza A virus hemagglutinin distinguishes sialyloligosaccharides in membrane-associated gangliosides as its receptor which mediates the adsorption and fusion processes of virus infection. Specificity for oligosaccharides and sialic acids and the sequence to which sialic acid is attached. J. Biol. Chem. 261, 17057-17061
126. Varghese, J. N., McKimm-Breschkin, J. L., Caldwell, J. B., Kortt, A. A., and Colman, P. M. (1992) The structure of the complex between influenza virus neuraminidase and sialic acid, the viral receptor. Proteins 14, 327-332
127. Sauter, N. K., Hanson, J. E., Glick, G. D., Brown, J. H., Crowther, R. L., Park, S. J., Skehel, J. J., and Wiley, D. C. (1992) Binding of influenza virus hemagglutinin to analogs of its cell-surface receptor, sialic acid: Analysis by proton nuclear magnetic resonance spectroscopy and X-ray crystallography. Biochemistry 31, 9609-9621
128. Stray, S. J., Cummings, R. D., and Air, G. M. (2000) Influenza virus infection of desialylated cells. Glycobiology 10, 649-658
129. Batinic, D., and Robey, F. A. (1992) The V3 region of the envelope glycoprotein of human immunodeficiency virus type 1 binds sulfated polysaccharides and CD4-derived synthetic peptides. J. Biol. Chem. 267, 6664-6671
130. Coeytaux, E., Coulaud, D., Le Cam, E., Danos, O., and Kichler, A. (2003) The cationic amphipathic alpha-helix of HIV-1 viral protein R (Vpr) binds to nucleic acids, permeabilizes membranes, and efficiently transfects cells. J. Biol. Chem. 278, 18110-18116
131. Giroglou, T., Florin, L., Schafer, F., Streeck, R. E., and Sapp, M. (2001) Human papillomavirus infection requires cell surface heparan sulfate. J. Virol. 75, 1565-1570
132. Langedijk, J. P. (2002) Translocation activity of C-terminal domain of pestivirus Erns and ribotoxin L3 loop. J. Biol. Chem. 277, 5308-5314
133. Oess, S., and Hildt, E. (2000) Novel cell permeable motif derived from the PreS2-domain of hepatitis-B virus surface antigens. Gene Ther. 7, 750-758
134. Schwarz-Linek, U., Werner, J. M., Pickford, A. R., Gurusiddappa, S., Kim, J. H., Pilka, E. S., Briggs, J. A., Gough, T. S., Hook, M., Campbell, I. D., and Potts, J. R. (2003) Pathogenic bacteria attach to human fibronectin through a tandem beta-zipper. Nature 423, 177-181
135. Hawking, F. (1978) Suramin: with special reference to onchocerciasis. Adv. Pharmacol. Chemother. 15, 289-322
136. Kirchhoff, L. V., Bacchi, C. J., Wittner, M., and Tanowitz, H. B. (2000) African trypanosomiasis. Curr. Treatment Options Infect. Dis. 2, 66-69
137. Cooper, P. J., and Nutman, T. B. (2002) Onchocerciasis. Curr. Treatment Options Infect Dis. 4, 327-335
138. Kaplan, L. D., Wolfe, P. R., Volberding, P. A., Feorino, P., Levy, J. A., Abrams, D. I., Kiprov, D., Wong, R., Kaufman, L., and Gottlieb, M. S. (1987) Lack of response to suramin in patients with AIDS and AIDS-related complex. Am. J. Med. 82, 615-620
139. Levine, A. M., Gill, P. S., Cohen, J., Hawkins, J. G., Formenti, S. C., Aguilar, S., Meyer, P. R., Krailo, M., Parker, J., and Rasheed, S. (1986) Suramin antiviral therapy in the acquired immunodeficiency syndrome. Clinical, immunological, and virologic results. Ann. Intern. Med. 105, 32-37
140. Vogelzang, N. J., Karrison, T., Stadler, W. M., Garcia, J., Cohn, H., Kugler, J., Troeger, T., Giannone, L., Arrieta, R., Ratain, M. J., and Vokes, E. E. (2004) A Phase II trial of suramin monthly × 3 for hormone-refractory prostate carcinoma. Cancer 100, 65-71
141. Szabo, S., Vattay, P., Scarbrough, E., and Folkman, J. (1991) Role of vascular factors, including angiogenesis, in the mechanisms of action of sucralfate. Am. J. Med. 91, 158S-160S
142. Curtis, C. L., Harwood, J. L., Dent, C. M., and Caterson, B. (2004) Biological basis for the benefit of nutraceutical supplementation in arthritis. Drug Discov. Today 9, 165-172
143. Lust, G., Williams, A. J., Burton-Wurster, N., Beck, K. A., and Rubin, G. (1992) Effects of intramuscular administration of glycosaminoglycan polysulfates on signs of incipient hip dysplasia in growing pups. Am. J. Vet. Res. 53, 1836-1843
144. Baskin, E., Saatci, U., Ciliv, G., Bakkaloglu, A., Besbas, N., Topaloglu, R., and Ozen, S. (2003) Urinary glycosaminoglycans in the course of familial Mediterranean fever. Eur. J. Pediatr. 162, 305-308
145. Lindahl, B., and Lindahl, U. (1997) Amyloid-specific heparan sulfate from human liver and spleen. J. Biol. Chem. 272, 26091-26094
146. Barabasi, A. L., and Albert, R. (1999) Emergence of scaling in random networks. Science 286, 509-512
147. Jeong, H., Tombor, B., Albert, R., Oltvai, Z. N., and Barabasi, A. L. (2000) The large-scale organization of metabolic networks. Nature 407, 651-654
148. Wuchty, S. (2001) Scale-free behavior in protein domain networks. Mol. Biol. Evol. 18, 1694-1702
149. Batada, N. N., Shepp, L. A., and Siegmund, D. O. (2004) Stochastic model of protein-protein interaction: Why signaling proteins need to be colocalized. Proc. Natl. Acad. Sci. U. S. A. 101, 6445-6449
150. Bar-Yam, Y., and Epstein, I. R. (2004) Response of complex networks to stimuli. Proc. Natl. Acad. Sci. U. S. A. 101, 4341-4345
151. Watts, D. J., and Strogatz, S. H. (1998) Collective dynamics of 'small-world' networks. Nature 393, 440-442
152. Maslov, S., and Sneppen, K. (2002) Specificity and stability in topology of protein networks. Science 296, 910-913
153. Ravasz, E., Somera, A. L., Mongru, D. A., Oltvai, Z. N., and Barabasi, A. L. (2002) Hierarchical organization of modularity in metabolic networks. Science 297, 1551-1555
154. Wuchty, S. (2003) Small worlds in RNA structures. Nucleic Acids Res. 31, 1108-1117
155. Mattick, J. S., and Gagen, M. J. (2001) The evolution of controlled multi-tasked gene networks: The role of introns and other noncoding RNAs in the development of complex organisms. Mol. Biol. Evol. 18, 1611-1630
156. Alon, U. (2003) Biological networks: The tinkerer as an engineer. Science 301, 1866-1867
157. Dunker, A. K., Brown, C. J., Lawson, J. D., Iakoucheva, L. M., and Obradovic, Z. (2002) Intrinsic disorder and protein function. Biochemistry 41, 6573-6582
158. Romero, P., Obradovic, Z., Kissinger, C. R., Villafranca, J. E., Garner, E., Guilliot, S., and Dunker, A. K. (1998) Thousands of proteins likely to have long disordered regions. Pac. Symp. Biocomput, 437-448
159. Dunker, A. K., and Obradovic, Z. (2001) The protein trinity-linking function and disorder. Nat. Biotechnol. 19, 805-806
160. Dunker, A. K., Lawson, J. D., Brown, C. J., Williams, R. M., Romero, P., Oh, J. S., Oldfield, C. J., Campen, A. M., Ratliff, C. M., Hipps, K. W., Ausio, J., Nissen, M. S., Reeves, R., Kang, C., Kissinger, C. R., Bailey, R. W., Griswold, M. D., Chiu, W., Garner, E. C., and Obradovic, Z. (2001) Intrinsically disordered protein. J. Mol. Graph. Model. 19, 26-59
161. Iakoucheva, L. M., Radivojac, P., Brown, C. J., O'Connor, T. R., Sikes, J. G., Obradovic, Z., and Dunker, A. K. (2004) The importance of intrinsic disorder for protein phosphorylation. Nucleic Acids Res. 32, 1037-1049. Print 2004
162. Stawiski, E. W., Gregoret, L. M., and Mandel-Gutfreund, Y. (2003) Annotating nucleic acid-binding function based on protein structure. J. Mol. Biol. 326, 1065-1079
163. Jones, S., Shanahan, H. P., Berman, H. M., and Thornton, J. M. (2003) Using electrostatic potentials to predict DNA-binding sites on DNA-binding proteins. Nucleic Acids Res. 31, 7189-7198
164. Jones, S., Barker, J. A., Nobeli, I., and Thornton, J. M. (2003) Using structural motif templates to identify proteins with DNA binding function. Nucleic Acids Res. 31, 2811-2823
165. Saito, A., Munakata, H., and Satoh, K. (2002) Glyco-western blotting: biotinylated dermatan sulfate as a probe for the detection of dermatan sulfate binding proteins using Western blotting. Connect Tissue Res. 43, 1-7
166. Sudhof, T. C. (2002) Synaptotagmins: Why so many? J. Biol. Chem. 277, 7629-7632
167. Steger, D. J., Haswell, E. S., Miller, A. L., Wente, S. R., and O'Shea, E. K. (2003) Regulation of chromatin remodeling by inositol polyphosphates. Science 299, 114-116
168. Couchman, J. R., Vogt, S., Lim, S. T., Lim, Y., Oh, E. S., Prestwich, G. D., Theibert, A., Lee, W., and Woods, A. (2002) Regulation of inositol phospholipid binding and signaling through syndecan-4. J. Biol. Chem. 277, 49296-49303
169. Verspohl, E. J., and Johannwille, B. (1998) Diadenosine polyphosphates in insulin-secreting cells: Interaction with specific receptors and degradation. Diabetes 47, 1727-1734
170. Kisselev, L. L., Justesen, J., Wolfson, A. D., and Frolova, L. Y. (1998) Diadenosine oligophosphates (Ap(n)A), a novel class of signalling molecules? FEBS Lett. 427, 157-163
171. Hanczyc, M. M., Fujikawa, S. M., and Szostak, J. W. (2003) Experimental models of primitive cellular compartments: encapsulation, growth, and division. Science 302, 618-622
172. Taylor, J. P., Hardy, J., and Fischbeck, K. H. (2002) Toxic proteins in neurodegenerative disease. Science 296, 1991-1995